The relationship between electrocardiographic changes and CMR features in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy

  • Xiuyu Chen
  • Tao Zhao
  • Minjie Lu
  • Gang Yin
  • Wei Xiangli
  • Shiliang Jiang
  • Sanjay Prasad
  • Shihua Zhao
Original Paper

Abstract

To investigate the relationship between electrocardiographic (ECG) abnormalities and left ventricular (LV) segmental hypertrophy and myocardial fibrosis assessed by cardiovascular magnetic resonance (CMR) in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy (HCM). 118 asymptomatic or mildly symptomatic patients with HCM were examined with late gadolinium enhancement (LGE) CMR, 12-lead ECG, and echocardiography. The distribution and magnitude of LV segmental hypertrophy and LGE were assessed and analyzed in relation to ECG abnormalities. Abnormal electrocardiograms were found in 113 of 118 (95 %) patients. Negative T waves were associated with greater apical septal thickness (P = 0.009) and an increased ratio of LV septum to free wall thickness (P = 0.01). Giant negative T waves (GNT) were found in 19 patients (16 %), and were associated with apical HCM (P < 0.001), greater apical thickness (P = 0.004), and increased ratio of LV apical to basal wall thickness (P < 0.001). However, no significant association was demonstrated between GNT and apical LGE (P = 0.71). Abnormal Q waves were associated with greater basal anteroseptal thickness (P = 0.001), maximal basal thickness (P = 0.004), and more segments with extensive LGE (>75 % wall thickness involved) (P = 0.001). LV hypertrophy was related to greater LV mass (P = 0.002) and LV end diastolic volume (P = 0.002). In addition, a modest but significant correlation was observed between maximum LV wall thickness and the Romhilt-Estes score (r = 0.41, P < 0.001). GNT were associated with apical HCM and an increased ratio of LV apical to basal wall thickness. Abnormal Q waves were related to basal anteroseptal hypertrophy and segmental extensive LGE.

Keywords

Cardiovascular magnetic resonance Electrocardiography Hypertrophic cardiomyopathy Late gadolinium enhancement 

References

  1. 1.
    Elliott P, McKenna WJ (2004) Hypertrophic cardiomyopathy. Lancet 363(9424):1881–1891PubMedCrossRefGoogle Scholar
  2. 2.
    Pelliccia A, Di Paolo FM, Quattrini FM et al (2008) Outcomes in athletes with marked ECG repolarization abnormalities. N Engl J Med 358(2):152–161PubMedCrossRefGoogle Scholar
  3. 3.
    Wilson MG, Sharma S, Carre F et al (2012) Significance of deep T-wave inversions in asymptomatic athletes with normal cardiovascular examinations: practical solutions for managing the diagnostic conundrum. Br J Sports Med 46(Suppl 1):51–58CrossRefGoogle Scholar
  4. 4.
    Papadakis M, Carre F, Kervio G et al (2011) The prevalence, distribution, and clinical outcomes of electrocardiographic repolarization patterns in male athletes of African/Afro-Caribbean origin. Eur Heart J 32(18):2304–2313PubMedCrossRefGoogle Scholar
  5. 5.
    Choudhury L, Mahrholdt H, Wagner A et al (2002) Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40(12):2156–2164PubMedCrossRefGoogle Scholar
  6. 6.
    Alfonso F, Nihoyannopoulos P, Stewart J et al (1990) Clinical significance of giant negative T waves in hypertrophic cardiomyopathy. J Am Coll Cardiol 15(5):965–971PubMedCrossRefGoogle Scholar
  7. 7.
    Savage DD, Seides SF, Clark CE et al (1978) Electrocardiographic findings in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. Circulation 58(3 Pt 1):402–408PubMedCrossRefGoogle Scholar
  8. 8.
    Dumont CA, Monserrat L, Soler R et al (2006) Interpretation of electrocardiographic abnormalities in hypertrophic cardiomyopathy with cardiac magnetic resonance. Eur Heart J 27(14):1725–1731PubMedCrossRefGoogle Scholar
  9. 9.
    Adabag AS, Maron BJ, Appelbaum E et al (2008) Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 51(14):1369–1374PubMedCrossRefGoogle Scholar
  10. 10.
    Konno T, Shimizu M, Ino H et al (2004) Diagnostic value of abnormal Q waves for identification of preclinical carriers of hypertrophic cardiomyopathy based on a molecular genetic diagnosis. Eur Heart J 25(3):246–251PubMedCrossRefGoogle Scholar
  11. 11.
    Sato T, Nakamura K, Yamanari H et al (1998) Relationship between electrocardiographic features and distribution of hypertrophy in patients with hypertrophic cardiomyopathy. Jpn Circ J 62(7):483–488PubMedCrossRefGoogle Scholar
  12. 12.
    Kwon DH, Smedira NG, Rodriguez ER et al (2009) Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. J Am Coll Cardiol 54(3):242–249PubMedCrossRefGoogle Scholar
  13. 13.
    To AC, Dhillon A, Desai MY (2011) Cardiac magnetic resonance in hypertrophic cardiomyopathy. JACC Cardiovasc Imaging 4(10):1123–1137PubMedCrossRefGoogle Scholar
  14. 14.
    Maron MS, Maron BJ, Harrigan C et al (2009) Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol 54(3):220–228PubMedCrossRefGoogle Scholar
  15. 15.
    Bluemke DA, Yang E (2012) Hypertrophic cardiomyopathy: refining the lens of cardiac magnetic resonance to evaluate late gadolinium enhancement. J Am Coll Cardiol 60(10):930–931PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Rudolph A, Abdel-Aty H, Bohl S et al (2009) Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol 53(3):284–291PubMedCrossRefGoogle Scholar
  17. 17.
    Chiribiri A, Conte MR, Bonamini R et al (2011) Late gadolinium enhancement and sudden cardiac death in hypertrophic cardiomyopathy. J Am Coll Cardiol 57(12):1402 (author reply 1402–1403)PubMedCrossRefGoogle Scholar
  18. 18.
    Prinz C, Schwarz M, Ilic I et al (2013) Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy. Can J Cardiol 29(3):358–363PubMedCrossRefGoogle Scholar
  19. 19.
    Bruder O, Wagner A, Jensen CJ et al (2010) Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 56(11):875–887PubMedCrossRefGoogle Scholar
  20. 20.
    O’Hanlon R, Grasso A, Roughton M et al (2010) Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 56(11):867–874PubMedCrossRefGoogle Scholar
  21. 21.
    Green JJ, Berger JS, Kramer CM et al (2012) Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. JACC Cardiovasc Imaging 5(4):370–377PubMedCrossRefGoogle Scholar
  22. 22.
    Todiere G, Aquaro GD, Piaggi P et al (2012) Progression of myocardial fibrosis assessed with cardiac magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 60(10):922–929PubMedCrossRefGoogle Scholar
  23. 23.
    Rowin EJ, Maron MS, Lesser JR et al (2012) CMR with late gadolinium enhancement in genotype positive-phenotype negative hypertrophic cardiomyopathy. JACC Cardiovasc Imaging 5(1):119–122PubMedCrossRefGoogle Scholar
  24. 24.
    Appelbaum E, Maron BJ, Adabag S et al (2012) Intermediate-signal-intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy. Circ Cardiovasc Imaging 5(1):78–85PubMedCrossRefGoogle Scholar
  25. 25.
    Delcre SD, Di Donna P, Leuzzi S et al (2013) Relationship of ECG findings to phenotypic expression in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study. Int J Cardiol 167(3):1038–1045PubMedCrossRefGoogle Scholar
  26. 26.
    Konno T, Fujino N, Hayashi K et al (2007) Differences in the diagnostic value of various criteria of negative T waves for hypertrophic cardiomyopathy based on a molecular genetic diagnosis. Clin Sci (Lond) 112(11):577–582CrossRefGoogle Scholar
  27. 27.
    Montgomery JV, Harris KM, Casey SA et al (2005) Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy. Am J Cardiol 96(2):270–275PubMedCrossRefGoogle Scholar
  28. 28.
    Harrigan CJ, Peters DC, Gibson CM et al (2011) Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging. Radiology 258(1):128–133PubMedCrossRefGoogle Scholar
  29. 29.
    Moon JC, Fisher NG, McKenna WJ et al (2004) Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 90(6):645–649PubMedCentralPubMedCrossRefGoogle Scholar
  30. 30.
    Spirito P, Bellone P, Harris KM et al (2000) Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342(24):1778–1785PubMedCrossRefGoogle Scholar
  31. 31.
    Moon JC, McKenna WJ, McCrohon JA et al (2003) Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41(9):1561–1567PubMedCrossRefGoogle Scholar
  32. 32.
    Matsubara K, Nakamura T, Kuribayashi T et al (2003) Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy. J Am Coll Cardiol 42(2):288–295PubMedCrossRefGoogle Scholar
  33. 33.
    Maron BJ, Wolfson JK, Ciro E et al (1983) Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy. Am J Cardiol 51(1):189–194PubMedCrossRefGoogle Scholar
  34. 34.
    Koga Y, Yamaga A, Hiyamuta K et al (2004) Mechanisms of abnormal Q waves in hypertrophic cardiomyopathy assessed by intracoronary electrocardiography. J Cardiovasc Electrophysiol 15(12):1402–1408PubMedCrossRefGoogle Scholar
  35. 35.
    Lemery R, Kleinebenne A, Nihoyannopoulos P et al (1990) Q waves in hypertrophic cardiomyopathy in relation to the distribution and severity of right and left ventricular hypertrophy. J Am Coll Cardiol 16(2):368–374PubMedCrossRefGoogle Scholar
  36. 36.
    Elliott PM, Gimeno Blanes JR, Mahon NG et al (2001) Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet 357(9254):420–424PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2014

Authors and Affiliations

  • Xiuyu Chen
    • 1
  • Tao Zhao
    • 1
  • Minjie Lu
    • 1
  • Gang Yin
    • 1
  • Wei Xiangli
    • 1
  • Shiliang Jiang
    • 1
  • Sanjay Prasad
    • 2
  • Shihua Zhao
    • 1
  1. 1.Department of Radiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical CollegeChinese Academy of Medical SciencesBeijingChina
  2. 2.NIHR Biomedical Research UnitRoyal Brompton HospitalLondonUK

Personalised recommendations